Dec 11, 2023 / 03:00PM GMT
Michael A. Metzger Syndax Pharmaceuticals - Inc. - CEO
Welcome CEO of Syndax. Welcome today to our investor event on a great Monday morning for us at ASH where we had a great weekend and expect to have a good couple of days to wrap up the meeting. It is, as you know, a really important time for the company as we advance two of our medicines to hopefully approval very shortly.
So I'm going to provide a short introduction, and we have a host of speakers today who are involved with our program thought leaders in the space who have done wonderful things for our programs. And so we'll let them speak to a variety of data that were presented either during the weekend and will be presented in the next day. Or two. So I'll introduce them and let them let them take the show from there.
So to start with our forward-looking statements, and I ask you to refer to our SEC disclosures for more information.
So just as introduction, I think most of all of you probably know we are very near commercialization. The Company is in a very unique place. We have two assets to hem assets that are very
Syndax Pharmaceuticals Inc to Host ASH Investor Event Transcript
Dec 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers